SignalPoint Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

SignalPoint Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-21,072	Closed	-$388K	–	211
2017 Q3	$388K	Buy	+21,072	New	+$393K	0.2%	135
2017 Q2	–	Sell	-21,861	Closed	-$493K	–	144
2017 Q1	$493K	Buy	21,861 +2,159	+11%	+$51.7K	0.14%	123
2016 Q4	$686K	Buy	19,702 +263	+1%	+$7.86K	0.18%	116
2016 Q3	$476K	Sell	19,439 -616	-3%	-$15.4K	0.13%	141
2016 Q2	$480K	Buy	20,055 +1,288	+7%	+$29.5K	0.2%	113
2016 Q1	$439K	Buy	18,767 +11,458	+157%	+$272K	0.19%	115
2015 Q4	$221K	Buy	+7,309	New	+$236K	0.1%	176

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SignalPoint Asset Management's AMAG Position: Q4 2017 in Review

SignalPoint Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 21,072 shares — an estimated $388K sold.

SignalPoint Asset Management first reported a position in AMAG in Q4 2015 and held it in 7 quarters. The position peaked at $686K in Q4 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

SignalPoint Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
SignalPoint Asset Management sold 21,072 AMAG Pharmaceuticals shares in Q4 2017, an estimated $388K.
SignalPoint Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 7 quarters.
SignalPoint Asset Management's AMAG Pharmaceuticals position peaked at $686K in Q4 2016.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on SignalPoint Asset Management's 13F filing for Q4 2017, filed 31 Jan 2018.